NCS Multistage Holdings Reports Strong Q1 Revenue Growth Driven by International Markets
NCS Multistage Holdings experienced a significant 14% year-over-year revenue increase in Q1 2025, with robust performance in Canadian and international markets despite U.S. project delays. The company's strong financial positioning and strategic international focus signal potential continued growth.
NCS Multistage Holdings (NASDAQ: NCSM) reported first quarter 2025 revenues of $50.0 million, marking a 14% increase from the previous year and representing the company's highest quarterly revenue since early 2020. The growth was primarily attributed to increased product sales in Canada and expanded service revenues across global markets.
Key financial highlights include a robust gross margin expansion from 40.1% in Q1 2024 to 43.7% in Q1 2025, and earnings per share rising from $0.83 to $1.58 year-over-year. The company's international segment demonstrated particular strength, with revenues growing 33.8% to $2.9 million, driven by tracer diagnostics projects in the Middle East and increased activity in the North Sea.
Despite a 34% sequential decline in international revenues due to project timing, management remains optimistic about long-term international market opportunities. The company's financial resilience is underscored by a strong liquidity position of $49.8 million, compared to just $7.6 million in debt.
NCS Multistage has set full-year guidance projecting revenues between $167.0 million and $175.0 million, with adjusted EBITDA expected to range from $20.0 million to $24.0 million. Analysts from Stonegate Capital Partners have valued the company between $32.17 and $38.36 per share, indicating potential for continued market performance.
The company's strategic focus on high-margin international markets, particularly in the Middle East and North Sea, coupled with its improved financial metrics, suggests NCS Multistage is well-positioned to navigate current market challenges and capitalize on emerging global opportunities.